Protein Phosphatase 2A as a Potential Target for Anticancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|11|1|38-46

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.11, Iss.1, 2011-01, pp. : 38-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Two Diseases with One Hit: Inhibiting a Potential Diabetes Target to Reduce Cancer Risk and to Improve Anti-Cancer Therapy

By  

Current Cancer Therapy Reviews, Vol. 5, Iss. 2, 2009-05 ,pp. : 111-121

Bentham Science Publishers

Access to resources Recommend Favorite

Frizzled2: A potential novel target for molecular pancreatic cancer therapy

By            

Oncology Letters, Vol. 7, Iss. 1, 2014-01 ,pp. : 74-78

Spandidos Publications

Access to resources Recommend Favorite

The Endothelin Receptor: A Novel Target for Anticancer Therapy

By Pirtskhalaishvili G.   Nelson J.B.  

American Journal of Cancer, Vol. 1, Iss. 2, 2002-02 ,pp. : 81-91

Adis International

Access to resources Recommend Favorite

Activated vitronectin as a target for anticancer therapy with human antibodies

By Bloemendal Haiko   Boer Hetty   Koop Elianne   Dongen Alice   Goldschmeding Roel   Landman Wil   Logtenberg Ton   Gebbink Martijn   Voest Emile  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 9, 2004-09 ,pp. : 799-808

Springer Publishing Company

Access to resources Recommend Favorite

Tyrosyl-DNA Phosphodiesterase as a Target for Anticancer Therapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 4, 2008-05 ,pp. : 381-389

Bentham Science Publishers

Access to resources Recommend Favorite